US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Revolution Medicines, Inc.

209.46

-2.2750-1.07%

Post-market: 209.500.0400+0.02%19:50 EDT

Volume:2.12M

Turnover:444.42M

Market Cap:44.89B

PE:-23.48

High:212.74

Open:212.06

Low:206.75

Close:211.74

52wk High:220.34

52wk Low:35.62

Shares:214.34M

Float Shares:184.00M

Volume Ratio:1.37

T/O Rate:1.15%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-8.9212

EPS(LYR):-5.9502

ROE:-79.09%

ROA:-30.12%

PB:17.23

PE(LYR):-35.20

Loading ...

Overview Company News Filings

Erasca Shares Crater After Cancer Trial Update Reveals Patient Death -- WSJ

Erasca Stock Sinks 50% in Race for 'Miracle' Cancer Drug. What's Behind the Historic Sell-Off. -- Barrons.com

Stock Track | Revolution Medicines Soars 9.91% Intraday on Positive Pancreatic Cancer Drug Data and Technical Rebound

BUZZ-Erasca drops after patient death reported in early cancer trial

There's a Revolution in Cancer. But Can Big Pharma Afford It? -- Heard on the Street -- WSJ

GenFleet says GFH276 IP independent, not tied to RevMed RAS patent disputes

Erasca Shares Tumble, Revolution Medicines Alleges Cancer Drug Patent Infringement

Revolution Medicines announces annual shareholder meeting

Revolution Medicines alleges Erasca ERAS-0015 infringes patent, misuses trade secrets

Mizuho Securities Keeps Their Buy Rating on Revolution Medicines (RVMD)

Revolution Medicines Adds RM-055 And First Line Data To RAS Story

Simply Wall St.

Stifel Nicolaus Remains a Buy on Revolution Medicines (RVMD)

Mizuho Raises Price Target on Revolution Medicines to $185 From $140, Keeps Outperform Rating

MT Newswires Live

Guggenheim Remains a Buy on Revolution Medicines (RVMD)

Revolution Medicines Price Target Maintained With a $169.00/Share by HC Wainwright & Co.

U.S. RESEARCH ROUNDUP-3M, Halliburton, Sherwin-Williams

Buy Rating on RVMD Driven by Promising Pancreatic Cancer Data and Next‑Generation RAS Franchise Potential

Revolution Medicines presents preclinical data on RM-055 catalytic RAS(ON) inhibitor at AACR

Revolution Medicines says Phase 3 trial shows daraxonrasib boosts survival in metastatic pancreatic cancer

UBS Adjusts Price Target on Revolution Medicines to $175 From $145, Maintains Buy Rating

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/RVMD/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"RVMD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RVMD\",,,,,undefined,":{"symbol":"RVMD","market":"US","secType":"STK","nameCN":"Revolution Medicines, Inc.","latestPrice":209.46,"timestamp":1787342400000,"preClose":211.735,"halted":0,"volume":2124325,"hourTrading":{"tag":"盘后","latestPrice":209.5,"preClose":209.46,"latestTime":"19:50 EDT","volume":57863,"amount":12119734.817,"timestamp":1787356254407,"change":0.04,"changeRate":0.000191,"amplitude":0.000191},"delay":0,"changeRate":-0.010744562778945406,"floatShares":184000000,"shares":214336418,"eps":-8.921187,"marketStatus":"Not Yet Opened","change":-2.275,"latestTime":"08-21 16:00:00 EDT","open":212.06,"high":212.74,"low":206.75,"amount":444419454.11149997,"amplitude":0.02829,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-8.921187,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":0,"adr":0,"listingDate":1581570000000,"exchange":"NASDAQ","adjPreClose":211.735,"preHourTrading":{"tag":"盘前","latestPrice":211.74,"preClose":211.735,"latestTime":"09:29 EDT","volume":1348,"amount":286109.19863999996,"timestamp":1787318999922,"change":0.005,"changeRate":0.000024,"amplitude":0.018466},"postHourTrading":{"tag":"盘后","latestPrice":209.5,"preClose":209.46,"latestTime":"19:50 EDT","volume":57863,"amount":12119734.817,"timestamp":1787356254407,"change":0.04,"changeRate":0.000191,"amplitude":0.000191},"volumeRatio":1.370853126120477,"impliedVol":0.5303,"impliedVolPercentile":0.3147},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RVMD\",,,,,undefined,":{"symbol":"RVMD","floatShares":184000000,"roa":"-30.12%","roe":"-79.09%","lyrEps":-5.950171,"volumeRatio":1.370853126120477,"shares":214336418,"dividePrice":0,"high":212.74,"amplitude":0.02829,"preClose":211.735,"low":206.75,"week52Low":35.62,"pbRate":"17.23","psRate":"60505.26","week52High":220.34,"institutionHeld":0,"latestPrice":209.46,"eps":-8.921187,"divideRate":0,"volume":2124325,"delay":0,"ttmEps":-8.921187,"open":212.06,"prevYearClose":79.65,"prevWeekClose":203.71,"prevMonthClose":187.53,"prevQuarterClose":187.28,"fiveDayClose":203.71,"twentyDayClose":189.23,"sixtyDayClose":153},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RVMD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-05","symbol":"RVMD","fiscalQuarterEnding":"2026/06","expectedEps":-1.93,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785902400000,"reportTimeType":"post","actualEps":-2.34},{"market":"US","date":"2026-05-06","symbol":"RVMD","fiscalQuarterEnding":"2026/03","expectedEps":-1.83,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778040000000,"reportTimeType":"post","actualEps":-2.29},{"market":"US","date":"2026-02-25","symbol":"RVMD","fiscalQuarterEnding":"2025/12","expectedEps":-1.56,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1771995600000,"reportTimeType":"post","actualEps":-1.86},{"market":"US","date":"2025-11-05","symbol":"RVMD","fiscalQuarterEnding":"2025/09","expectedEps":-1.39,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762318800000,"reportTimeType":"post","actualEps":-1.61},{"market":"US","date":"2025-08-06","symbol":"RVMD","fiscalQuarterEnding":"2025/06","expectedEps":-0.94,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":-1.31}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RVMD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RVMD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3636,"buy":0.5909,"hold":0.0455,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5909,"analysts":22,"updateTime":1782705600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RVMD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RVMD","date":"2026-08-21","current":-23.478938,"percent":0.038367,"low":-29.983875,"twenty":-15.421639,"median":-11.807302,"eighty":-9.155597,"high":-5.200973,"avg":-12.903704,"sd":4.903095,"marketCap":45382521465},"quantilePoints":[{"date":"2021-08-27","current":-14.680164,"twenty":-35.063632,"median":-29.677719,"eighty":-20.017939,"marketCap":2097795507},{"date":"2021-09-03","current":-14.983963,"twenty":-35.014857,"median":-29.622676,"eighty":-19.718062,"marketCap":2141208322},{"date":"2021-09-10","current":-15.318656,"twenty":-35.014043,"median":-29.554382,"eighty":-19.461564,"marketCap":2189035999},{"date":"2021-09-17","current":-16.080727,"twenty":-34.931292,"median":-29.401065,"eighty":-19.128837,"marketCap":2297935941},{"date":"2021-09-24","current":-15.812973,"twenty":-34.786478,"median":-29.374181,"eighty":-19.029603,"marketCap":2259673799},{"date":"2021-10-01","current":-14.994261,"twenty":-34.755446,"median":-29.335032,"eighty":-18.644341,"marketCap":2142679943},{"date":"2021-10-08","current":-14.304278,"twenty":-34.745047,"median":-29.310402,"eighty":-18.527595,"marketCap":2044081346},{"date":"2021-10-15","current":-13.8769,"twenty":-34.734758,"median":-29.247595,"eighty":-18.445873,"marketCap":1983009081},{"date":"2021-10-22","current":-14.05712,"twenty":-34.714071,"median":-29.125884,"eighty":-18.095635,"marketCap":2008762446},{"date":"2021-10-29","current":-15.153884,"twenty":-34.648998,"median":-29.017933,"eighty":-17.885492,"marketCap":2165490066},{"date":"2021-11-05","current":-17.352562,"twenty":-34.580278,"median":-28.958078,"eighty":-17.646163,"marketCap":2479681115},{"date":"2021-11-12","current":-14.346829,"twenty":-34.492308,"median":-28.914638,"eighty":-17.476881,"marketCap":2419147952},{"date":"2021-11-19","current":-13.000858,"twenty":-34.414098,"median":-28.85313,"eighty":-17.352562,"marketCap":2192191641},{"date":"2021-11-26","current":-11.807838,"twenty":-34.412604,"median":-28.801275,"eighty":-17.20603,"marketCap":1991025820},{"date":"2021-12-03","current":-11.405795,"twenty":-34.3029,"median":-28.497349,"eighty":-17.023962,"marketCap":1923233675},{"date":"2021-12-10","current":-10.763399,"twenty":-34.187789,"median":-28.442942,"eighty":-16.776035,"marketCap":1814913617},{"date":"2021-12-17","current":-11.305284,"twenty":-34.083597,"median":-28.405363,"eighty":-16.474835,"marketCap":1906285639},{"date":"2021-12-23","current":-12.03945,"twenty":-34.013007,"median":-28.38164,"eighty":-16.42397,"marketCap":2030079990},{"date":"2021-12-31","current":-10.999381,"twenty":-33.942417,"median":-28.201619,"eighty":-16.346779,"marketCap":1854704659},{"date":"2022-01-07","current":-10.024863,"twenty":-33.76864,"median":-28.048463,"eighty":-16.058071,"marketCap":1690382395},{"date":"2022-01-14","current":-11.453865,"twenty":-33.634734,"median":-27.953181,"eighty":-15.823646,"marketCap":1931339257},{"date":"2022-01-21","current":-9.924352,"twenty":-33.600309,"median":-27.927252,"eighty":-15.745005,"marketCap":1673434358},{"date":"2022-01-28","current":-8.683262,"twenty":-33.572919,"median":-27.803555,"eighty":-15.342342,"marketCap":1464162955},{"date":"2022-02-04","current":-9.321287,"twenty":-33.538069,"median":-27.527148,"eighty":-15.221853,"marketCap":1571746141},{"date":"2022-02-11","current":-9.382468,"twenty":-33.35472,"median":-27.507196,"eighty":-14.988082,"marketCap":1582062337},{"date":"2022-02-18","current":-8.687632,"twenty":-33.099087,"median":-27.430755,"eighty":-14.738865,"marketCap":1464899826},{"date":"2022-02-25","current":-8.661412,"twenty":-33.042596,"median":-27.356123,"eighty":-14.46596,"marketCap":1460478599},{"date":"2022-03-04","current":-6.864099,"twenty":-32.958086,"median":-27.106898,"eighty":-14.327964,"marketCap":1284211088},{"date":"2022-03-11","current":-7.994236,"twenty":-32.941769,"median":-26.996531,"eighty":-14.248668,"marketCap":1495649655},{"date":"2022-03-18","current":-8.121129,"twenty":-32.904507,"median":-26.81427,"eighty":-14.145685,"marketCap":1519390126},{"date":"2022-03-25","current":-9.647806,"twenty":-32.821938,"median":-26.630154,"eighty":-14.012701,"marketCap":1805017664},{"date":"2022-04-01","current":-10.171238,"twenty":-32.790169,"median":-26.321811,"eighty":-13.877367,"marketCap":1902947106},{"date":"2022-04-08","current":-9.707287,"twenty":-32.696096,"median":-25.809173,"eighty":-13.834677,"marketCap":1816146010},{"date":"2022-04-14","current":-9.552636,"twenty":-32.655638,"median":-25.508846,"eighty":-13.634891,"marketCap":1787212311},{"date":"2022-04-22","current":-8.48198,"twenty":-32.605595,"median":-25.411043,"eighty":-13.186917,"marketCap":1586902089},{"date":"2022-04-29","current":-7.923582,"twenty":-32.604969,"median":-25.251002,"eighty":-13.000858,"marketCap":1482430833},{"date":"2022-05-06","current":-6.745162,"twenty":-32.556286,"median":-25.104297,"eighty":-12.432753,"marketCap":1261959147},{"date":"2022-05-13","current":-5.605175,"twenty":-32.548789,"median":-24.984266,"eighty":-12.03945,"marketCap":1163421328},{"date":"2022-05-20","current":-5.626637,"twenty":-32.521167,"median":-24.877571,"eighty":-11.729177,"marketCap":1167876036},{"date":"2022-05-27","current":-6.045147,"twenty":-32.510824,"median":-24.637509,"eighty":-11.453865,"marketCap":1254742849},{"date":"2022-06-03","current":-6.842821,"twenty":-32.499218,"median":-24.219623,"eighty":-11.34811,"marketCap":1420309509},{"date":"2022-06-10","current":-6.406425,"twenty":-32.436346,"median":-23.895094,"eighty":-11.243229,"marketCap":1329730439},{"date":"2022-06-17","current":-6.442195,"twenty":-32.379374,"median":-23.366068,"eighty":-11.125239,"marketCap":1337154953},{"date":"2022-06-24","current":-6.749818,"twenty":-32.364381,"median":-23.214917,"eighty":-10.925091,"marketCap":1401005772},{"date":"2022-07-01","current":-7.472374,"twenty":-32.356442,"median":-22.940713,"eighty":-10.752911,"marketCap":1550980953},{"date":"2022-07-08","current":-8.373781,"twenty":-32.351591,"median":-22.671372,"eighty":-10.549267,"marketCap":1738078703},{"date":"2022-07-15","current":-8.334434,"twenty":-32.34811,"median":-22.432492,"eighty":-10.427254,"marketCap":1729911738},{"date":"2022-07-22","current":-9.416787,"twenty":-32.336859,"median":-20.395581,"eighty":-10.154349,"marketCap":1954567219},{"date":"2022-07-29","current":-9.517907,"twenty":-32.317101,"median":-20.179552,"eighty":-10.138472,"marketCap":1975555860},{"date":"2022-08-05","current":-10.524893,"twenty":-32.295373,"median":-19.937304,"eighty":-10.061207,"marketCap":2184567746},{"date":"2022-08-12","current":-9.934512,"twenty":-32.249624,"median":-19.823476,"eighty":-9.887644,"marketCap":2230148976},{"date":"2022-08-19","current":-8.821128,"twenty":-32.202462,"median":-19.563716,"eighty":-9.821893,"marketCap":1980210927},{"date":"2022-08-26","current":-8.305455,"twenty":-32.188128,"median":-19.268933,"eighty":-9.766873,"marketCap":1864450146},{"date":"2022-09-02","current":-8.336708,"twenty":-32.148872,"median":-19.152186,"eighty":-9.713705,"marketCap":1871465951},{"date":"2022-09-09","current":-8.446093,"twenty":-32.08878,"median":-19.105488,"eighty":-9.655919,"marketCap":1896021268},{"date":"2022-09-16","current":-7.899168,"twenty":-32.064554,"median":-19.029603,"eighty":-9.51714,"marketCap":1773244683},{"date":"2022-09-23","current":-7.199884,"twenty":-32.002117,"median":-18.761088,"eighty":-9.470081,"marketCap":1616266049},{"date":"2022-09-30","current":-7.703837,"twenty":-31.933655,"median":-18.632667,"eighty":-9.406812,"marketCap":1729395902},{"date":"2022-10-07","current":-7.188165,"twenty":-31.892408,"median":-18.527595,"eighty":-9.339431,"marketCap":1613635122},{"date":"2022-10-14","current":-7.192071,"twenty":-31.843605,"median":-18.47506,"eighty":-9.283077,"marketCap":1614512098},{"date":"2022-10-21","current":-7.26239,"twenty":-31.799278,"median":-18.410849,"eighty":-9.19045,"marketCap":1630297658},{"date":"2022-10-28","current":-8.149191,"twenty":-31.791895,"median":-18.32329,"eighty":-9.019584,"marketCap":1829371122},{"date":"2022-11-04","current":-8.008553,"twenty":-31.779106,"median":-18.034343,"eighty":-8.822296,"marketCap":1797800000},{"date":"2022-11-11","current":-8.038796,"twenty":-31.743478,"median":-17.885492,"eighty":-8.744159,"marketCap":1968492013},{"date":"2022-11-18","current":-7.400623,"twenty":-31.611046,"median":-17.727885,"eighty":-8.684136,"marketCap":1812220207},{"date":"2022-11-25","current":-7.930016,"twenty":-31.608208,"median":-17.643244,"eighty":-8.652672,"marketCap":1941854774},{"date":"2022-12-02","current":-9.257124,"twenty":-31.600562,"median":-17.605302,"eighty":-8.582548,"marketCap":2266829098},{"date":"2022-12-09","current":-8.622578,"twenty":-31.589267,"median":-17.430183,"eighty":-8.622578,"marketCap":2111445200},{"date":"2022-12-16","current":-8.811129,"twenty":-31.528745,"median":-17.352562,"eighty":-8.622578,"marketCap":2157616415},{"date":"2022-12-23","current":-7.991658,"twenty":-31.520105,"median":-17.22743,"eighty":-8.579066,"marketCap":1956949209},{"date":"2022-12-30","current":-8.637082,"twenty":-31.479483,"median":-17.126643,"eighty":-8.567621,"marketCap":2114996832},{"date":"2023-01-06","current":-8.122193,"twenty":-31.410856,"median":-17.065386,"eighty":-8.466377,"marketCap":1988913897},{"date":"2023-01-13","current":-10.910571,"twenty":-31.358383,"median":-16.893151,"eighty":-8.452882,"marketCap":2671715141},{"date":"2023-01-20","current":-9.978694,"twenty":-31.337393,"median":-16.786158,"eighty":-8.462846,"marketCap":2443522788},{"date":"2023-01-27","current":-10.058466,"twenty":-31.313581,"median":-16.610494,"eighty":-8.476856,"marketCap":2463056764},{"date":"2023-02-03","current":-9.391286,"twenty":-31.29487,"median":-16.436017,"eighty":-8.510662,"marketCap":2299681694},{"date":"2023-02-10","current":-8.912656,"twenty":-31.274712,"median":-16.42397,"eighty":-8.560653,"marketCap":2182477839},{"date":"2023-02-17","current":-9.27888,"twenty":-31.260931,"median":-16.363929,"eighty":-8.574289,"marketCap":2272156546},{"date":"2023-02-24","current":-8.822007,"twenty":-31.242788,"median":-16.33277,"eighty":-8.579762,"marketCap":2160280139},{"date":"2023-03-03","current":-10.647267,"twenty":-31.197689,"median":-16.087084,"eighty":-8.579762,"marketCap":2648028624},{"date":"2023-03-10","current":-8.855897,"twenty":-31.16187,"median":-15.941671,"eighty":-8.590554,"marketCap":2202505834},{"date":"2023-03-17","current":-9.244089,"twenty":-31.149495,"median":-15.821867,"eighty":-8.624028,"marketCap":2299051129},{"date":"2023-03-24","current":-8.92415,"twenty":-31.112663,"median":-15.766631,"eighty":-8.630902,"marketCap":2219480831},{"date":"2023-03-31","current":-9.239823,"twenty":-31.043539,"median":-15.5066,"eighty":-8.63548,"marketCap":2297990191},{"date":"2023-04-06","current":-8.710858,"twenty":-31.019551,"median":-15.344402,"eighty":-8.63663,"marketCap":2166433966},{"date":"2023-04-14","current":-9.457381,"twenty":-30.941368,"median":-15.318656,"eighty":-8.637082,"marketCap":2352097994},{"date":"2023-04-21","current":-10.421462,"twenty":-30.878322,"median":-15.197652,"eighty":-8.651136,"marketCap":2591869823},{"date":"2023-04-28","current":-9.797218,"twenty":-30.870624,"median":-14.994261,"eighty":-8.652672,"marketCap":2436616994},{"date":"2023-05-05","current":-10.357181,"twenty":-30.85027,"median":-14.899002,"eighty":-8.661412,"marketCap":2575882625},{"date":"2023-05-12","current":-10.509705,"twenty":-30.781796,"median":-14.741954,"eighty":-8.675846,"marketCap":2723653028},{"date":"2023-05-17","current":-10.514164,"twenty":-30.750065,"median":-14.680164,"eighty":-8.680978,"marketCap":2724808597},{"date":"2023-05-22","current":-10.604414,"twenty":-30.742758,"median":-14.638971,"eighty":-8.681739,"marketCap":2748197512},{"date":"2023-06-02","current":-10.337765,"twenty":-30.715961,"median":-14.433006,"eighty":-8.684136,"marketCap":2679093900},{"date":"2023-06-06","current":-10.592107,"twenty":-30.691594,"median":-14.417559,"eighty":-8.685884,"marketCap":2745008115},{"date":"2023-06-16","current":-10.313152,"twenty":-30.665151,"median":-14.343576,"eighty":-8.689125,"marketCap":2672715105},{"date":"2023-06-23","current":-10.243413,"twenty":-30.661,"median":-14.332598,"eighty":-8.692112,"marketCap":2654641852},{"date":"2023-06-30","current":-10.756199,"twenty":-30.642434,"median":-14.304278,"eighty":-8.695537,"marketCap":2787533415},{"date":"2023-07-07","current":-10.747994,"twenty":-30.599184,"median":-14.268235,"eighty":-8.696853,"marketCap":2785407150},{"date":"2023-07-14","current":-10.88337,"twenty":-30.571275,"median":-14.227042,"eighty":-8.700327,"marketCap":2820490522},{"date":"2023-07-21","current":-11.002336,"twenty":-30.55928,"median":-14.165252,"eighty":-8.70235,"marketCap":2851321365},{"date":"2023-07-28","current":-10.325458,"twenty":-30.54682,"median":-14.131782,"eighty":-8.703075,"marketCap":2675904502},{"date":"2023-08-04","current":-13.431201,"twenty":-30.534927,"median":-14.05712,"eighty":-8.706952,"marketCap":3480776375},{"date":"2023-08-11","current":-10.985831,"twenty":-30.490465,"median":-13.92878,"eighty":-8.714953,"marketCap":3254354629},{"date":"2023-08-18","current":-10.794196,"twenty":-30.453438,"median":-13.8769,"eighty":-8.732356,"marketCap":3197586283},{"date":"2023-08-25","current":-11.726573,"twenty":-30.358451,"median":-13.852085,"eighty":-8.737762,"marketCap":3473786122},{"date":"2023-09-01","current":-12.518909,"twenty":-30.291198,"median":-13.806045,"eighty":-8.744159,"marketCap":3708501401},{"date":"2023-09-08","current":-11.826075,"twenty":-30.284917,"median":-13.70183,"eighty":-8.748813,"marketCap":3503261994},{"date":"2023-09-15","current":-11.995599,"twenty":-30.253212,"median":-13.486971,"eighty":-8.748872,"marketCap":3553480147},{"date":"2023-09-22","current":-11.232745,"twenty":-30.224947,"median":-13.356839,"eighty":-8.756739,"marketCap":3327498460},{"date":"2023-09-29","current":-10.407241,"twenty":-30.203399,"median":-13.174045,"eighty":-8.762048,"marketCap":3082957891},{"date":"2023-10-06","current":-9.332812,"twenty":-30.16501,"median":-13.144804,"eighty":-8.77058,"marketCap":2764677471},{"date":"2023-10-13","current":-8.941174,"twenty":-30.134266,"median":-12.958889,"eighty":-8.792291,"marketCap":2648661710},{"date":"2023-10-20","current":-10.714629,"twenty":-30.114487,"median":-12.616295,"eighty":-8.800251,"marketCap":3174016099},{"date":"2023-10-27","current":-7.356147,"twenty":-30.095825,"median":-12.606316,"eighty":-8.795475,"marketCap":2179126225},{"date":"2023-11-03","current":-7.81429,"twenty":-30.060759,"median":-12.501235,"eighty":-8.752019,"marketCap":2314842775},{"date":"2023-11-10","current":-6.620103,"twenty":-30.047837,"median":-12.424237,"eighty":-8.737762,"marketCap":2193485193},{"date":"2023-11-17","current":-10.554208,"twenty":-30.030888,"median":-12.332162,"eighty":-8.737762,"marketCap":3496999768},{"date":"2023-11-24","current":-10.718109,"twenty":-30.000059,"median":-12.21303,"eighty":-8.742996,"marketCap":3551306118},{"date":"2023-12-01","current":-11.587279,"twenty":-29.985066,"median":-12.109842,"eighty":-8.748813,"marketCap":3839294334},{"date":"2023-12-08","current":-12.158448,"twenty":-29.940089,"median":-12.106157,"eighty":-8.748872,"marketCap":4028543733},{"date":"2023-12-15","current":-12.987885,"twenty":-29.936663,"median":-12.117213,"eighty":-8.756739,"marketCap":4303366774},{"date":"2023-12-22","current":-13.047485,"twenty":-29.882158,"median":-12.163415,"eighty":-8.760986,"marketCap":4323114537},{"date":"2023-12-29","current":-14.587158,"twenty":-29.867332,"median":-12.21303,"eighty":-8.765461,"marketCap":4833265092},{"date":"2024-01-05","current":-13.921622,"twenty":-29.865533,"median":-12.242539,"eighty":-8.77058,"marketCap":4612748400},{"date":"2024-01-12","current":-14.055722,"twenty":-29.805418,"median":-12.332162,"eighty":-8.792291,"marketCap":4657180868},{"date":"2024-01-19","current":-13.191519,"twenty":-29.796607,"median":-12.415721,"eighty":-8.798659,"marketCap":4370838299},{"date":"2024-01-26","current":-13.891822,"twenty":-29.785014,"median":-12.501235,"eighty":-8.808953,"marketCap":4602874519},{"date":"2024-02-02","current":-14.035856,"twenty":-29.698709,"median":-12.606316,"eighty":-8.816931,"marketCap":4650598280},{"date":"2024-02-09","current":-15.088793,"twenty":-29.677719,"median":-12.710562,"eighty":-8.820579,"marketCap":4999475434},{"date":"2024-02-16","current":-14.641791,"twenty":-29.659728,"median":-12.916919,"eighty":-8.821831,"marketCap":4851367208},{"date":"2024-02-23","current":-14.428224,"twenty":-29.635698,"median":-13.000858,"eighty":-8.824984,"marketCap":4780604389},{"date":"2024-03-01","current":-11.126124,"twenty":-29.60188,"median":-12.952402,"eighty":-8.830519,"marketCap":4855073227},{"date":"2024-03-08","current":-11.89982,"twenty":-29.567836,"median":-12.759417,"eighty":-8.846692,"marketCap":5192688564},{"date":"2024-03-15","current":-12.069655,"twenty":-29.549023,"median":-12.639,"eighty":-8.858457,"marketCap":5266799247},{"date":"2024-03-22","current":-12.239491,"twenty":-29.460095,"median":-12.548969,"eighty":-8.864302,"marketCap":5340909931},{"date":"2024-03-28","current":-11.971528,"twenty":-29.40149,"median":-12.518909,"eighty":-8.873697,"marketCap":5223979741},{"date":"2024-04-05","current":-11.375216,"twenty":-29.393986,"median":-12.428588,"eighty":-8.893019,"marketCap":4963768897},{"date":"2024-04-12","current":-14.119006,"twenty":-29.381608,"median":-12.432753,"eighty":-8.907079,"marketCap":6161068163},{"date":"2024-04-19","current":-13.522694,"twenty":-29.367289,"median":-12.501235,"eighty":-8.909315,"marketCap":5900857318},{"date":"2024-04-26","current":-13.8038,"twenty":-29.352329,"median":-12.548969,"eighty":-8.913841,"marketCap":6023522918},{"date":"2024-05-03","current":-15.311943,"twenty":-29.337105,"median":-12.639,"eighty":-8.919031,"marketCap":6681626470},{"date":"2024-05-10","current":-12.75881,"twenty":-29.319095,"median":-12.75881,"eighty":-8.93096,"marketCap":6178734201},{"date":"2024-05-17","current":-13.283471,"twenty":-29.310603,"median":-12.746886,"eighty":-8.953134,"marketCap":6432812990},{"date":"2024-05-24","current":-12.990478,"twenty":-29.296302,"median":-12.759417,"eighty":-8.972364,"marketCap":6290924835},{"date":"2024-05-31","current":-13.058616,"twenty":-29.274087,"median":-12.91212,"eighty":-8.97648,"marketCap":6323922080},{"date":"2024-06-07","current":-13.743401,"twenty":-29.260932,"median":-12.989182,"eighty":-8.986745,"marketCap":6655544397},{"date":"2024-06-14","current":-13.157416,"twenty":-29.219252,"median":-13.004106,"eighty":-8.995267,"marketCap":6371768086},{"date":"2024-06-21","current":-13.017733,"twenty":-29.194791,"median":-13.000858,"eighty":-9.004739,"marketCap":6304123733},{"date":"2024-06-28","current":-13.222147,"twenty":-29.125884,"median":-13.032609,"eighty":-9.005202,"marketCap":6403115469},{"date":"2024-07-05","current":-12.786065,"twenty":-29.10502,"median":-13.010919,"eighty":-9.05152,"marketCap":6191933099},{"date":"2024-07-12","current":-15.378709,"twenty":-29.046393,"median":-13.058616,"eighty":-9.07038,"marketCap":7447478286},{"date":"2024-07-19","current":-15.719398,"twenty":-29.008869,"median":-13.107958,"eighty":-9.073204,"marketCap":7612464513},{"date":"2024-07-26","current":-15.821605,"twenty":-28.971852,"median":-13.144804,"eighty":-9.075352,"marketCap":7661960381},{"date":"2024-08-02","current":-14.990324,"twenty":-28.959284,"median":-13.159294,"eighty":-9.078336,"marketCap":7259393988},{"date":"2024-08-09","current":-13.80176,"twenty":-28.952047,"median":-13.186917,"eighty":-9.088056,"marketCap":7165970654},{"date":"2024-08-16","current":-13.785675,"twenty":-28.923049,"median":-13.211799,"eighty":-9.110957,"marketCap":7157618707},{"date":"2024-08-23","current":-14.039833,"twenty":-28.913715,"median":-13.226286,"eighty":-9.122932,"marketCap":7289579472},{"date":"2024-08-30","current":-13.714896,"twenty":-28.889231,"median":-13.275208,"eighty":-9.148532,"marketCap":7120870140},{"date":"2024-09-06","current":-13.460738,"twenty":-28.865184,"median":-13.307173,"eighty":-9.155161,"marketCap":6988909375},{"date":"2024-09-13","current":-14.059136,"twenty":-28.85313,"median":-13.370657,"eighty":-9.170299,"marketCap":7299601809},{"date":"2024-09-20","current":-14.612493,"twenty":-28.822017,"median":-13.38788,"eighty":-9.180362,"marketCap":7586908791},{"date":"2024-09-27","current":-14.210344,"twenty":-28.733437,"median":-13.413244,"eighty":-9.183247,"marketCap":7378110112},{"date":"2024-10-04","current":-15.22376,"twenty":-28.584764,"median":-13.42888,"eighty":-9.201243,"marketCap":7904282782},{"date":"2024-10-11","current":-16.240393,"twenty":-28.493659,"median":-13.447869,"eighty":-9.21728,"marketCap":8432125842},{"date":"2024-10-18","current":-16.224307,"twenty":-28.47389,"median":-13.485962,"eighty":-9.231265,"marketCap":8423773895},{"date":"2024-10-25","current":-14.934213,"twenty":-28.453985,"median":-13.505779,"eighty":-9.2387,"marketCap":7753947734},{"date":"2024-11-01","current":-17.723519,"twenty":-28.43718,"median":-13.530841,"eighty":-9.239492,"marketCap":9202175369},{"date":"2024-11-08","current":-17.929605,"twenty":-28.426015,"median":-13.549208,"eighty":-9.239823,"marketCap":10167179992},{"date":"2024-11-15","current":-16.354387,"twenty":-28.402209,"median":-13.553351,"eighty":-9.241502,"marketCap":9273935025},{"date":"2024-11-22","current":-16.834962,"twenty":-28.388854,"median":-13.59382,"eighty":-9.243502,"marketCap":9546450439},{"date":"2024-11-29","current":-17.161279,"twenty":-28.382984,"median":-13.599077,"eighty":-9.247065,"marketCap":9731491769},{"date":"2024-12-06","current":-15.665191,"twenty":-28.352774,"median":-13.629525,"eighty":-9.253671,"marketCap":8883118675},{"date":"2024-12-13","current":-14.667989,"twenty":-28.272382,"median":-13.644118,"eighty":-9.256981,"marketCap":8317644509},{"date":"2024-12-20","current":-14.3584,"twenty":-28.187897,"median":-13.679939,"eighty":-9.258574,"marketCap":8142088804},{"date":"2024-12-27","current":-14.407283,"twenty":-28.146447,"median":-13.685233,"eighty":-9.26075,"marketCap":8169808126},{"date":"2025-01-03","current":-14.377953,"twenty":-28.06298,"median":-13.698466,"eighty":-9.26075,"marketCap":8153176533},{"date":"2025-01-10","current":-13.615387,"twenty":-28.039753,"median":-13.70032,"eighty":-9.275254,"marketCap":7720755112},{"date":"2025-01-17","current":-13.129822,"twenty":-28.012756,"median":-13.698121,"eighty":-9.281462,"marketCap":7445409848},{"date":"2025-01-24","current":-13.35794,"twenty":-27.974892,"median":-13.684981,"eighty":-9.284891,"marketCap":7574766684},{"date":"2025-01-31","current":-13.99667,"twenty":-27.938362,"median":-13.683094,"eighty":-9.286872,"marketCap":7936965823},{"date":"2025-02-07","current":-13.748999,"twenty":-27.927744,"median":-13.698121,"eighty":-9.305989,"marketCap":7796521259},{"date":"2025-02-14","current":-13.253657,"twenty":-27.900337,"median":-13.683094,"eighty":-9.312333,"marketCap":7515632130},{"date":"2025-02-21","current":-13.471999,"twenty":-27.549957,"median":-13.678462,"eighty":-9.312333,"marketCap":7639445101},{"date":"2025-02-28","current":-12.621558,"twenty":-27.43754,"median":-13.619774,"eighty":-9.312333,"marketCap":7574108901},{"date":"2025-03-07","current":-12.147553,"twenty":-27.052106,"median":-13.57987,"eighty":-9.305989,"marketCap":7289661512},{"date":"2025-03-14","current":-12.11967,"twenty":-26.733207,"median":-13.542742,"eighty":-9.305989,"marketCap":7272929313},{"date":"2025-03-21","current":-11.806765,"twenty":-26.048313,"median":-13.507846,"eighty":-9.305989,"marketCap":7085156853},{"date":"2025-03-28","current":-11.571311,"twenty":-25.490858,"median":-13.471999,"eighty":-9.305989,"marketCap":6943862726},{"date":"2025-04-04","current":-9.703172,"twenty":-25.218993,"median":-13.436152,"eighty":-9.305989,"marketCap":5822805370},{"date":"2025-04-11","current":-11.066325,"twenty":-25.002048,"median":-13.416495,"eighty":-9.312333,"marketCap":6640824004},{"date":"2025-04-17","current":-11.388525,"twenty":-24.776212,"median":-13.38788,"eighty":-9.312333,"marketCap":6834173863},{"date":"2025-04-25","current":-12.011238,"twenty":-23.795402,"median":-13.335128,"eighty":-9.305989,"marketCap":7207859649},{"date":"2025-05-02","current":-12.639005,"twenty":-22.971228,"median":-13.283471,"eighty":-9.305989,"marketCap":7584578134},{"date":"2025-05-09","current":-10.794078,"twenty":-22.46336,"median":-13.226286,"eighty":-9.305989,"marketCap":7528934128},{"date":"2025-05-16","current":-10.559076,"twenty":-20.181887,"median":-13.186917,"eighty":-9.305989,"marketCap":7365018689},{"date":"2025-05-23","current":-10.36146,"twenty":-19.835151,"median":-13.144804,"eighty":-9.305989,"marketCap":7227180707},{"date":"2025-05-30","current":-10.437569,"twenty":-19.477908,"median":-13.099382,"eighty":-9.305989,"marketCap":7280266957},{"date":"2025-06-06","current":-10.735327,"twenty":-19.114828,"median":-13.02228,"eighty":-9.305989,"marketCap":7487955268},{"date":"2025-06-13","current":-10.978341,"twenty":-18.869661,"median":-12.990478,"eighty":-9.305989,"marketCap":7657458733},{"date":"2025-06-20","current":-10.663224,"twenty":-18.562619,"median":-12.881458,"eighty":-9.299644,"marketCap":7437663031},{"date":"2025-06-27","current":-10.008957,"twenty":-18.463385,"median":-12.772741,"eighty":-9.299644,"marketCap":6981307549},{"date":"2025-07-03","current":-10.113106,"twenty":-18.297004,"median":-12.734961,"eighty":-9.299644,"marketCap":7053951891},{"date":"2025-07-11","current":-10.281346,"twenty":-17.976026,"median":-12.650637,"eighty":-9.299644,"marketCap":7171300444},{"date":"2025-07-18","current":-10.428222,"twenty":-17.795598,"median":-12.615234,"eighty":-9.299644,"marketCap":7273747593},{"date":"2025-07-25","current":-9.939525,"twenty":-17.635003,"median":-12.544605,"eighty":-9.299644,"marketCap":6932877987},{"date":"2025-08-01","current":-9.952877,"twenty":-17.510008,"median":-12.441797,"eighty":-9.299644,"marketCap":6942191364},{"date":"2025-08-08","current":-8.04536,"twenty":-17.386734,"median":-12.335246,"eighty":-9.28683,"marketCap":6533314990},{"date":"2025-08-15","current":-8.29167,"twenty":-17.227741,"median":-12.226287,"eighty":-9.258574,"marketCap":6733333503},{"date":"2025-08-22","current":-8.39756,"twenty":-17.114968,"median":-12.166195,"eighty":-9.240942,"marketCap":6819322771},{"date":"2025-08-29","current":-8.822272,"twenty":-16.963885,"median":-12.133612,"eighty":-9.215532,"marketCap":7164214506},{"date":"2025-09-05","current":-8.966145,"twenty":-16.825201,"median":-12.107278,"eighty":-9.160498,"marketCap":7281047750},{"date":"2025-09-12","current":-10.644276,"twenty":-16.632002,"median":-12.076403,"eighty":-9.165399,"marketCap":8643790705},{"date":"2025-09-19","current":-10.409476,"twenty":-16.360805,"median":-12.036866,"eighty":-9.165399,"marketCap":8453118851},{"date":"2025-09-26","current":-9.785644,"twenty":-16.298315,"median":-11.983563,"eighty":-9.165399,"marketCap":7946529906},{"date":"2025-10-03","current":-10.51997,"twenty":-16.17003,"median":-11.932203,"eighty":-9.165399,"marketCap":8542846783},{"date":"2025-10-10","current":-10.960796,"twenty":-16.019241,"median":-11.883373,"eighty":-9.165399,"marketCap":8900823841},{"date":"2025-10-17","current":-11.436151,"twenty":-15.923821,"median":-11.824165,"eighty":-9.165399,"marketCap":9286840879},{"date":"2025-10-24","current":-12.301689,"twenty":-15.827099,"median":-11.824165,"eighty":-9.165399,"marketCap":9989709673},{"date":"2025-10-31","current":-13.551655,"twenty":-15.764391,"median":-11.824165,"eighty":-9.165399,"marketCap":11004756895},{"date":"2025-11-07","current":-11.939877,"twenty":-15.679879,"median":-11.815047,"eighty":-9.165399,"marketCap":11473959202},{"date":"2025-11-14","current":-12.951315,"twenty":-15.574558,"median":-11.815047,"eighty":-9.165399,"marketCap":12445929045},{"date":"2025-11-21","current":-14.057749,"twenty":-15.418688,"median":-11.815047,"eighty":-9.165399,"marketCap":13509187973},{"date":"2025-11-28","current":-15.642968,"twenty":-15.380753,"median":-11.815047,"eighty":-9.165399,"marketCap":15032548036},{"date":"2025-12-05","current":-15.78781,"twenty":-15.364762,"median":-11.815047,"eighty":-9.165399,"marketCap":15171738296},{"date":"2025-12-12","current":-15.793845,"twenty":-15.364762,"median":-11.815047,"eighty":-9.165399,"marketCap":15177537890},{"date":"2025-12-19","current":-15.280862,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":14684572387},{"date":"2025-12-26","current":-16.332981,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":15695634967},{"date":"2026-01-02","current":-16.023179,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":15397922468},{"date":"2026-01-09","current":-21.603631,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":20760613858},{"date":"2026-01-16","current":-24.798208,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":23830532362},{"date":"2026-01-23","current":-23.90099,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":22968326032},{"date":"2026-01-30","current":-19.75488,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":18984004851},{"date":"2026-02-06","current":-19.342482,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":18587699250},{"date":"2026-02-13","current":-19.579862,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":18815816620},{"date":"2026-02-20","current":-20.668191,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":19861676765},{"date":"2026-02-27","current":-17.788098,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":20123693112},{"date":"2026-03-06","current":-17.454238,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":19745997277},{"date":"2026-03-13","current":-16.653698,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":18840344852},{"date":"2026-03-20","current":-17.392928,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":19676636588},{"date":"2026-03-27","current":-16.327876,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":18471742334},{"date":"2026-04-02","current":-17.279065,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":19547823880},{"date":"2026-04-10","current":-16.855147,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":19068244259},{"date":"2026-04-17","current":-27.750933,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":31394658062},{"date":"2026-04-24","current":-25.001309,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":28284006272},{"date":"2026-05-01","current":-26.793491,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":30311503450},{"date":"2026-05-08","current":-22.086858,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":30296565868},{"date":"2026-05-15","current":-23.165977,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":31776793175},{"date":"2026-05-22","current":-23.826223,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":32682454103},{"date":"2026-05-29","current":-23.965712,"twenty":-15.360619,"median":-11.807838,"eighty":-9.160498,"marketCap":32873790919},{"date":"2026-06-05","current":-24.129999,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":33099143168},{"date":"2026-06-12","current":-23.12878,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":31725770024},{"date":"2026-06-18","current":-24.452372,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":33541343809},{"date":"2026-06-26","current":-27.614117,"twenty":-15.360619,"median":-11.807838,"eighty":-9.160498,"marketCap":37878311634},{"date":"2026-07-02","current":-29.0617,"twenty":-15.360619,"median":-11.807838,"eighty":-9.160498,"marketCap":39863962589},{"date":"2026-07-10","current":-29.622754,"twenty":-15.360619,"median":-11.807838,"eighty":-9.160498,"marketCap":40633561782},{"date":"2026-07-17","current":-27.770654,"twenty":-15.360619,"median":-11.807838,"eighty":-9.160498,"marketCap":38093034061},{"date":"2026-07-24","current":-29.253884,"twenty":-15.360619,"median":-11.807838,"eighty":-9.160498,"marketCap":40127582202},{"date":"2026-07-31","current":-29.783941,"twenty":-15.3547,"median":-11.807302,"eighty":-9.155597,"marketCap":40854662102},{"date":"2026-08-07","current":-23.782199,"twenty":-15.3547,"median":-11.807302,"eighty":-9.155597,"marketCap":42053706148},{"date":"2026-08-14","current":-24.484716,"twenty":-15.366538,"median":-11.807302,"eighty":-9.155597,"marketCap":43295956436},{"date":"2026-08-21","current":-25.66471,"twenty":-15.421639,"median":-11.807302,"eighty":-9.155597,"marketCap":45382521465}],"updateTime":1787525263597},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RVMD\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2631538452","title":"Erasca Shares Crater After Cancer Trial Update Reveals Patient Death -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2631538452","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631538452?lang=en_us&edition=fundamental","pubTime":"2026-04-29 03:58","pubTimestamp":1777406280,"startTime":"0","endTime":"0","summary":"Erasca is on pace to lose about $2.7 billion in market value Tuesday after disclosing that a patient who took its experimental cancer drug died.Monday afternoon, in a presentation to investors, Erasca disclosed that a patient in one of its pancreatic cancer trials developed serious lung inflammation a month into taking the company's experimental medication, stopped treatment and ultimately died.\"It was a very rare event,\" Chief Executive Jonathan Lim said, adding a trial investigator had suggested that \"if the patient had continued supportive care, the outcome might have been different.\". The death overshadowed a result that Lim said showed the company's drug compared \"favorably\" with rival drugs in development. Shares were down 48% Tuesday afternoon.Erasca's results combined data from two separate trials-one in the U.S., one in China-that had different rules for patient selection. The company didn't disclose safety data from the China study, which analysts at TD Cowen said left questi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","ERAS","RVMD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631458484","title":"Erasca Stock Sinks 50% in Race for 'Miracle' Cancer Drug. What's Behind the Historic Sell-Off. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2631458484","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631458484?lang=en_us&edition=fundamental","pubTime":"2026-04-29 00:29","pubTimestamp":1777393740,"startTime":"0","endTime":"0","summary":"A confluence of safety concerns and underwhelming clinical data sent Erasca stock into a historic tailspin on Tuesday. A legal threat from a competitor was proving to be the least of the company's problems.Erasca late Monday reported positive Phase 1 trial results for ERAS-0015, a therapeutic drug candidate tailored to patients with lung and pancreatic cancer. The preliminary data was accrued from ongoing dose escalation trials in the U.S., as well as a trial in China.Investors quickly drew parallels to daraxonrasib, the high-profile lead asset from Revolution Medicines. Daraxonrasib has been on the receiving end of a storm of media coverage following an endorsement from former Nebraska Sen. Ben Sasse.Erasca cratered 50%, putting the stock on pace for its largest single-day percentage drop on record, according to Dow Jones Market Data. Revolution stock advanced 8.8%.Revolution's patent, viewed by Barron's, covers the use of so-called Ras inhibitors to treat cancer. Ras inhibitors block","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","IE00BZ1G4Q59.USD","NVOX","HMYY","BK4588","BK4532","IE00BKVL7J92.USD","LU1093756168.USD","BK4599","LU1093756325.SGD","HIYY","HIMY","ERAS","HIMZ","BK4007","BK4196","LU0154236417.USD","BK4139","NVOH","BK4585","RVMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184289842","title":"Stock Track | Revolution Medicines Soars 9.91% Intraday on Positive Pancreatic Cancer Drug Data and Technical Rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1184289842","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184289842?lang=en_us&edition=fundamental","pubTime":"2026-04-28 21:35","pubTimestamp":1777383335,"startTime":"0","endTime":"0","summary":"Shares of Revolution Medicines, Inc. (RVMD) surged 9.91% during Tuesday's intraday session, marking a significant upward move for the biotech stock.The sharp rise is attributed to continued investor...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["RVMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630637224","title":"BUZZ-Erasca drops after patient death reported in early cancer trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2630637224","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630637224?lang=en_us&edition=fundamental","pubTime":"2026-04-28 18:04","pubTimestamp":1777370687,"startTime":"0","endTime":"0","summary":"BUZZ-Erasca drops after patient death reported in early cancer trial** Shares of drug developer Erasca ERAS.O fall 36.7% to $12.12 premarket after the company discloses death of a patient in an early-stage trial of experimental cancer drug ERAS0015** Company says the 66-year-old pancreatic cancer patient developed severe pneumonitis, roughly a month after starting ERAS0015; patient later chose to withdraw supportive care and died** ERAS says it does not expect the case to represent a broader safety concern** \"The single pneumonitis-related death occurred in the PDAC cohort in a patient who withdrew care before resolution, and management does not expect pneumonitis frequency to rise meaningfully with broader use\" - Clear Street** In the same study, ERAS0015 produced tumor responses in 62% of previously treated lung cancer patients, versus 38% for Revolution Medicines' RVMD.O daraxonrasib in a comparable early trial** Revolution's shares up 8.4% premarket** RBC Capital Markets says that ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nL4N41B126:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","ERAS","RVMD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630712743","title":"There's a Revolution in Cancer. But Can Big Pharma Afford It? -- Heard on the Street -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2630712743","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630712743?lang=en_us&edition=fundamental","pubTime":"2026-04-28 17:30","pubTimestamp":1777368600,"startTime":"0","endTime":"0","summary":"There may soon be a drug for pancreatic cancer. For patients who have faced one of medicine's most merciless diagnoses, it is a genuine breakthrough.For Wall Street, it raises a different question entirely: Can anyone afford to acquire the drug's developer?Revolution Medicines has advanced what could turn out to be one of the most important cancer drugs in a generation. In a late-stage clinical trial, its pill nearly doubled survival compared with chemotherapy. Approval from the U.S. Food and Drug Administration could come later this year.Merck, a powerhouse in cancer with its blockbuster Keytruda soon going off patent, would be a logical buyer. But Merck has spent roughly $25 billion on acquisitions in the past year, leaving little room for a megadeal without threatening its investment-grade credit rating. AbbVie once accepted a downgrade to buy Allergan, and recovered. But that kind of risk has grown rarer. Stock deals are another option, bu","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RVMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630021325","title":"GenFleet says GFH276 IP independent, not tied to RevMed RAS patent disputes","url":"https://stock-news.laohu8.com/highlight/detail?id=2630021325","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630021325?lang=en_us&edition=fundamental","pubTime":"2026-04-28 12:29","pubTimestamp":1777350595,"startTime":"0","endTime":"0","summary":"GenFleet issued a clarification saying its Pan RAS  inhibitor GFH276 is unrelated to patent or trade secret disputes referenced in correspondence from Revolution Medicines on RAS inhibitors.GenFleet stated GFH276 was developed using independent, proprietary intellectual property, with no exposure to infringement or trade secret risks tied to those disputes.Company highlighted a global patent portfolio for its Pan RAS program, citing publication of a core patent covering GFH276’s compound structure on March 6, 2025.GenFleet said patent protection for that core filing is projected to run through 2044.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genfleet Therapeutics  Inc. published the original content used to generate this news brief","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDLb3WJHz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595","BK4139","BK1161","RVMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630343297","title":"Erasca Shares Tumble, Revolution Medicines Alleges Cancer Drug Patent Infringement","url":"https://stock-news.laohu8.com/highlight/detail?id=2630343297","media":"Dow Jones","labels":["policyRegulatory","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630343297?lang=en_us&edition=fundamental","pubTime":"2026-04-28 06:04","pubTimestamp":1777327440,"startTime":"0","endTime":"0","summary":"$Erasca(ERAS)$ shares fell after $Revolution Medicines(RVMD)$ alleged that the company's development of its ERAS-0015 cancer treatment infringes on existing patents and relies on stolen trade...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Erasca Shares Tumble, Revolution Medicines Alleges Cancer Drug Patent Infringement","news_tag":"policyRegulatory,movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","RVMD","ERAS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630348796","title":"Revolution Medicines announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2630348796","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630348796?lang=en_us&edition=fundamental","pubTime":"2026-04-28 05:32","pubTimestamp":1777325543,"startTime":"0","endTime":"0","summary":"Revolution Medicines schedules annual stockholder meeting online on June 18, 2026.Shareholders will vote on election of two Class III directors, including Alexis Borisy, Mark A. Goldsmith.Advisory say-on-pay vote on named executive officer compensation is also slated.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Revolution Medicines Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 27, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nNDLbQCn27:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RVMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630391832","title":"Revolution Medicines alleges Erasca ERAS-0015 infringes patent, misuses trade secrets","url":"https://stock-news.laohu8.com/highlight/detail?id=2630391832","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630391832?lang=en_us&edition=fundamental","pubTime":"2026-04-27 20:34","pubTimestamp":1777293280,"startTime":"0","endTime":"0","summary":"Revolution Medicines counsel sent Erasca letter on April 24, 2026 alleging ERAS-0015 infringes U.S. Patent No. 12,409,225 under doctrine of equivalents.Letter also alleged trade secret misappropriation tied to a patent relating to ERAS-0015, with Erasca accused of liability as a licensee.RevMed demanded Erasca stop making or selling ERAS-0015 in U.S. outside Hatch-Waxman safe harbor.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Erasca Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 27, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nNDL1hWdTc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","RVMD","ERAS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630387213","title":"Mizuho Securities Keeps Their Buy Rating on Revolution Medicines (RVMD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2630387213","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630387213?lang=en_us&edition=fundamental","pubTime":"2026-04-26 20:19","pubTimestamp":1777205975,"startTime":"0","endTime":"0","summary":"In a report released on April 24, Joseph Catanzaro from Mizuho Securities maintained a Buy rating on Revolution Medicines, with a price target of $...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/mizuho-securities-keeps-their-buy-rating-on-revolution-medicines-rvmd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/mizuho-securities-keeps-their-buy-rating-on-revolution-medicines-rvmd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RVMD","MFG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630802492","title":"Revolution Medicines Adds RM-055 And First Line Data To RAS Story","url":"https://stock-news.laohu8.com/highlight/detail?id=2630802492","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630802492?lang=en_us&edition=fundamental","pubTime":"2026-04-26 05:14","pubTimestamp":1777151654,"startTime":"0","endTime":"0","summary":"Revolution Medicines (NasdaqGS:RVMD) reported preclinical data for RM-055, a new class of catalytic RAS(ON) inhibitors that convert oncogenic RAS to an inactive state in multiple cancer models.\nThe company also shared updated first line clinical data for daraxonrasib in untreated metastatic pancreatic cancer, supporting further Phase 3 evaluation.\nThese announcements expand beyond prior late stage updates that focused on second line pancreatic cancer data and related financings.\n\nFor...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rvmd/revolution-medicines/news/revolution-medicines-adds-rm-055-and-first-line-data-to-ras","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rvmd/revolution-medicines/news/revolution-medicines-adds-rm-055-and-first-line-data-to-ras","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ON","LU1861220033.SGD","BK4585","IE00BD6J9T35.USD","BK4139","LU1720051108.HKD","BK4512","LU1978683503.SGD","LU1861219969.SGD","BK4141","LU1861214812.USD","BK4588","BK4605","LU0124384867.USD","LU1720051017.SGD","LU1548497426.USD","LU2357305700.SGD","LU1854104046.USD","LU2360107325.USD","LU0724618433.USD","LU1861215975.USD","IE00BFMHRM44.USD","RVMD","IE00BZ199S13.USD","LU2298322129.HKD","LU1854103824.USD","RM","BK4166","LU0348723411.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629535218","title":"Stifel Nicolaus Remains a Buy on Revolution Medicines (RVMD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2629535218","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629535218?lang=en_us&edition=fundamental","pubTime":"2026-04-23 22:36","pubTimestamp":1776954993,"startTime":"0","endTime":"0","summary":"Stifel Nicolaus analyst Laura Prendergast maintained a Buy rating on Revolution Medicines today and set a price target of $215.00. Prendergast cove...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-remains-a-buy-on-revolution-medicines-rvmd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-remains-a-buy-on-revolution-medicines-rvmd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","SF","RVMD","BK4127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629019834","title":"Mizuho Raises Price Target on Revolution Medicines to $185 From $140, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2629019834","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629019834?lang=en_us&edition=fundamental","pubTime":"2026-04-23 20:54","pubTimestamp":1776948841,"startTime":"0","endTime":"0","summary":"Revolution Medicines (RVMD) has an average rating of buy and mean price target of $169.05, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from maj","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RVMD","MFG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629283557","title":"Guggenheim Remains a Buy on Revolution Medicines (RVMD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2629283557","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629283557?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:21","pubTimestamp":1776943260,"startTime":"0","endTime":"0","summary":"Guggenheim analyst Michael Morris maintained a Buy rating on Revolution Medicines yesterday and set a price target of $175.00. The company’s shares...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/guggenheim-remains-a-buy-on-revolution-medicines-rvmd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/guggenheim-remains-a-buy-on-revolution-medicines-rvmd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RVMD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629045028","title":"Revolution Medicines Price Target Maintained With a $169.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2629045028","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629045028?lang=en_us&edition=fundamental","pubTime":"2026-04-22 20:03","pubTimestamp":1776859380,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RVMD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 22, 2026 08:03 ET (12:03 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629101397","title":"U.S. RESEARCH ROUNDUP-3M, Halliburton, Sherwin-Williams","url":"https://stock-news.laohu8.com/highlight/detail?id=2629101397","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629101397?lang=en_us&edition=fundamental","pubTime":"2026-04-22 16:10","pubTimestamp":1776845431,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-3M, Halliburton, Sherwin-WilliamsApril 22 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including 3M, Hall","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nL4N4150LF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVMD","ALBG","GOOGL","MANH","NOC","AGCO","ALB","BOKF","SSNC","DGX","GOOX","ZION","AUB","GGLS","MMM","GOU","MSCI","NTRS","AFRM","UNHG","VMI","GOOP","STLD","HAL","AEP","MRK","DHI","GOOY","AFRU","TSCO","SHW","NIC","ALK","TXRH","OFG","EWBC","NJR","GGLL","FIGR","WTFC","GOOW","MCRI","AXTA","HBCP","VICR","UNH","AM","UNHW","MUSA","DHR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629013356","title":"Buy Rating on RVMD Driven by Promising Pancreatic Cancer Data and Next‑Generation RAS Franchise Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2629013356","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629013356?lang=en_us&edition=fundamental","pubTime":"2026-04-22 15:55","pubTimestamp":1776844528,"startTime":"0","endTime":"0","summary":"In a report released today, Charles Zhu from LifeSci Capital maintained a Buy rating on Revolution Medicines, with a price target of $185.00. Charl...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-on-rvmd-driven-by-promising-pancreatic-cancer-data-and-next‑generation-ras-franchise-potential-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-on-rvmd-driven-by-promising-pancreatic-cancer-data-and-next‑generation-ras-franchise-potential-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RVMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629653330","title":"Revolution Medicines presents preclinical data on RM-055 catalytic RAS(ON) inhibitor at AACR","url":"https://stock-news.laohu8.com/highlight/detail?id=2629653330","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629653330?lang=en_us&edition=fundamental","pubTime":"2026-04-22 05:30","pubTimestamp":1776807022,"startTime":"0","endTime":"0","summary":"Revolution Medicines announced preclinical results for RM-055, an oral mutant-targeted catalytic RAS inhibitor, set for presentation April 21, 2026 at AACR Annual Meeting.Studies showed deep, durable tumor regressions across multiple KRAS G12 mutant cancer models, supporting potential to extend durability of RAS-targeted therapy.RM-055 also showed activity in tumors that had escaped prior RAS inhibitor treatment, positioning program as a potential option to counter acquired resistance.Company highlighted mutant-selective pathway suppression in tumor models with reduced impact on normal tissue signaling, which could support combination use and dosing flexibility.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nNDL4JHFbX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVMD","SG9999014021.USD","SG9999014013.SGD","NDAQ","LU0314104364.USD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00BGHQF748.EUR","SG9999014039.USD","IE00BN0W2T93.GBP","LU2095319765.USD","LU2210150020.SGD","IE00BN0W2W23.USD","BK4112","IE00BN0W2V16.EUR","SG9999014005.SGD","BK4585","BK4588","BK4139","IE00BKPKM429.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629053486","title":"Revolution Medicines says Phase 3 trial shows daraxonrasib boosts survival in metastatic pancreatic cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2629053486","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629053486?lang=en_us&edition=fundamental","pubTime":"2026-04-21 23:23","pubTimestamp":1776785000,"startTime":"0","endTime":"0","summary":"Revolution Medicines flagged upcoming presentation of pivotal Phase 3 RASolute 302 results for daraxonrasib in previously treated metastatic pancreatic cancer at ASCO annual meeting.Data will be delivered in Plenary Session on May 31, 2026 in Chicago.Topline results already disclosed showed daraxonrasib met primary and key secondary endpoints versus standard-of-care IV chemotherapy.Study showed clinically meaningful improvement in survival outcomes without new safety concerns highlighted in announcement.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nNDL99kPz1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","IE00BGHQF748.EUR","IE00BKPKM429.USD","IE00B64PRP62.GBP","SG9999014021.USD","SG9999014013.SGD","LU2210149790.SGD","BK4585","BK4139","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","NDAQ","IE00BN0W2W23.USD","SG9999014039.USD","LU2210150020.SGD","BK4588","IE00B3QW5Z07.USD","RVMD","LU0314104364.USD","LU2095319765.USD","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628172412","title":"UBS Adjusts Price Target on Revolution Medicines to $175 From $145, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2628172412","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628172412?lang=en_us&edition=fundamental","pubTime":"2026-04-20 23:18","pubTimestamp":1776698300,"startTime":"0","endTime":"0","summary":"Revolution Medicines (RVMD) has an average rating of buy and mean price target of $165.60, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from maj","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RVMD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}